Rocket Pharmaceuticals (RCKTW) News Today $0.04 -0.01 (-19.31%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrendsBuy This Stock Why is Rocket Pharmaceuticals Dropping Today?Rocket Pharmaceuticals, Inc. (RCKTW) shares have fallen after multiple reports that a patient in its Danon disease gene therapy trial died, prompting the U.S. Food and Drug Administration to place a clinical hold on the Phase II study. Short interest data as of May 27 shows zero shares shorted, although the figures appear anomalous with no recorded change from the May 12 level. The company provided a routine update on its Phase II RP-A501 Danon disease trial, and its stock was highlighted among trending tickers. FDA imposed a hold on the RP-A501 Phase II trial after a trial participant’s death, raising concerns over program safety and timelines. News of the trial pause led to reports of significant pre-market share declines and broader investor caution. Posted 1h agoAI Generated. May Contain Errors. RCKTW Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period CoreWeave, Rocket Pharmaceuticals, SoundHound: Trending TickersMay 27 at 3:26 PM | finance.yahoo.comFDA halts Rocket Pharma's gene therapy trial as patient diesMay 27 at 3:26 PM | msn.comRocket Pharmaceuticals Stock Drops Pre-Market After FDA Pauses Gene Therapy Trial Over Patient Death: Retail Turns BullishMay 27 at 3:26 PM | msn.comRocket Pharmaceuticals Stock Craters After Gene Therapy Patient DiesMay 27 at 3:26 PM | msn.comRocket Pharmaceuticals stock tumbles after patient death halts trialMay 27 at 8:59 AM | za.investing.comRocket Pharmaceuticals Shares Down as Trial Patient Dies of ComplicationsMay 27 at 8:59 AM | marketwatch.comRocket Pharma plunges after FDA clinical hold on mid-stage trialMay 27 at 8:59 AM | msn.comRocket Pharmaceuticals Provides Update on Phase 2 Clinical Trial of RP-A501 for Danon DiseaseMay 27 at 8:59 AM | finance.yahoo.comUS FDA pauses gene therapy trial by Rocket Pharma after patient deathMay 27 at 8:59 AM | msn.comRocket Pharmaceuticals Presents Preliminary Data from Phase 1 Clinical Trial of RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy at 28th Annual Meeting of the American Society of ...May 17, 2025 | businesswire.comRocket Pharma's Gene Therapy Shows Promise in ACM Patients, Says AnalystMay 16, 2025 | benzinga.comRocket Companies and UWM take losses yet remain hopeful amid economic uncertaintyMay 9, 2025 | msn.comRocket posts net loss in first quarterMay 9, 2025 | detroitnews.comFINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Lab USAApril 28, 2025 | tmcnet.comIs Rocket Pharmaceuticals (NASDAQ:RCKT) In A Good Position To Deliver On Growth Plans?April 17, 2025 | finance.yahoo.comRocket Lab Shares Rise After Selection to Participate in US, UK Military ProgramsApril 14, 2025 | marketwatch.comRocket Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare ConferenceApril 3, 2025 | finance.yahoo.comRocket acquires Mr. Cooper in $9.4 billion mergerMarch 31, 2025 | msn.comRocket Lab nets major Pentagon contractMarch 29, 2025 | msn.comRocket Lab USA Shares Rise After DoD Selection to Compete for LaunchesMarch 28, 2025 | marketwatch.comIs Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) the Best US Stock Under $10 to Buy Right Now?March 26, 2025 | msn.comRocket Pharmaceuticals’ SWOT analysis: gene therapy stock poised for growth amid challengesMarch 26, 2025 | uk.investing.comCantor Fitzgerald maintains Overweight on Rocket Pharmaceuticals stockMarch 26, 2025 | uk.investing.comBMO Capital Initiates Coverage of Rocket Pharmaceuticals (RCKT) with Outperform RecommendationMarch 12, 2025 | msn.comRocket Pharmaceuticals price target raised to $52 from $51 at ScotiabankMarch 3, 2025 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: BioRestorative Therapies (BRTX), Rocket Pharmaceuticals (RCKT)March 1, 2025 | markets.businessinsider.comMorgan Stanley Reaffirms Their Buy Rating on Rocket Pharmaceuticals (RCKT)February 28, 2025 | markets.businessinsider.comDan Gilbert's Rocket Companies swings back to profitability in 2024February 27, 2025 | usatoday.comRocket Lab (RKLB) Shares Climb 5% Ahead of Quarterly EarningsFebruary 26, 2025 | uk.finance.yahoo.comRCKT stock touches 52-week low at $9.76 amid market challengesFebruary 11, 2025 | msn.comRocket Pharmaceuticals appoints new board memberJanuary 28, 2025 | msn.comRCKT stock touches 52-week low at $10.11 amid market challengesJanuary 21, 2025 | msn.comRocket Pharmaceuticals price target lowered to $48 from $49 at JPMorganJanuary 8, 2025 | markets.businessinsider.comRocket Pharmaceuticals initiated with an Outperform at WedbushDecember 30, 2024 | markets.businessinsider.comWedbush starts Rocket Pharmaceuticals with Outperform into ‘inflection year’December 30, 2024 | markets.businessinsider.comRocket Pharmaceuticals Announces Proposed Public Offering of Common StockDecember 11, 2024 | finance.yahoo.comRocket Pharma Prices Upsized Public Offering Of 13.2 Mln Shares At $12.50/shr; Stock DownDecember 11, 2024 | markets.businessinsider.comRocket Pharmaceuticals announces $150M common stock offeringDecember 11, 2024 | markets.businessinsider.comRocket Pharmaceuticals Announces Pricing of Upsized Public Offering of Common StockDecember 11, 2024 | finance.yahoo.comSpaceX Rival Rocket Lab's Stock Hits Record High on Double Launch, CHIPS AwardNovember 25, 2024 | msn.comRocket Pharmaceuticals Receives Buy Rating Due to Promising RP-A501 Data and FDA Alignment for Danon Disease TreatmentNovember 20, 2024 | markets.businessinsider.comRocket Pharmaceuticals Advances Genetic Therapies PipelineNovember 20, 2024 | markets.businessinsider.comPromising Advancements in Gene Therapy: Buy Recommendation for Rocket PharmaceuticalsNovember 19, 2024 | markets.businessinsider.comFormer Rocket Set to Return to Houston TonightNovember 13, 2024 | msn.comBank of America Securities Remains a Buy on Rocket Pharmaceuticals (RCKT)November 13, 2024 | markets.businessinsider.comLebanon Rocket Fire Kills Two In Israel: First RespondersNovember 12, 2024 | barrons.comPromising Developments and Strong Financial Outlook Justify Buy Rating for Rocket PharmaceuticalsNovember 11, 2024 | markets.businessinsider.comRocket Pharmaceuticals: Strategic Advancements and Strong Financial Position Justify Buy RatingNovember 11, 2024 | markets.businessinsider.comPositive Outlook for Rocket Pharmaceuticals Amidst Significant Trial Progress and Regulatory EngagementNovember 8, 2024 | markets.businessinsider.comRocket Pharmaceuticals to Participate in the UBS Global Healthcare ConferenceNovember 8, 2024 | finance.yahoo.com Get Rocket Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RCKTW and its competitors with MarketBeat's FREE daily newsletter. Email Address RCKTW Media Mentions By Week RCKTW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RCKTW News Sentiment▼-0.011.02▲Average Medical News Sentiment RCKTW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RCKTW Articles This Week▼52▲RCKTW Articles Average Week Get Rocket Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RCKTW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BCTXW News ENGNW News FBIOP News GOVXW News LEXXW News NTHI News RVPHW News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RCKTW) was last updated on 5/27/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
